Statin therapy, cardiac events, and survival in patients with non-small cell lung cancer receiving definitive radiotherapy

Radiother Oncol. 2023 Oct:187:109825. doi: 10.1016/j.radonc.2023.109825. Epub 2023 Jul 27.

Authors

Nikhil Yegya-Raman¹, Cole Friedes², Michelle Iocolano², Steven J Feigenberg²

Affiliations

¹ Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: Nikhil.Yegya-Raman@pennmedicine.upenn.edu.
² Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

PMID: 37516360
DOI: 10.1016/j.radonc.2023.109825

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / radiotherapy
Cardiovascular Diseases*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Lung Neoplasms*
Neoplasm Staging

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors